Back to Search Start Over

Association of

Authors :
Harmesh, Lal
Bhavna, Sharma
Vasudha, Sambyal
Kamlesh, Guleria
Neeti Rajan, Singh
Manjit Singh, Uppal
Mridu, Manjari
Meena, Sudan
Source :
Journal of cancer research and therapeutics. 18(6)
Publication Year :
2022

Abstract

Breast cancer is a complex, multifactorial disease that arises as a result of interactions between multiple genes and environmental factors. Methylenetetrahydrofolate reductase (MTHFR) is a low susceptibility gene, involved in folate metabolism. It assists in conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate which further leads to DNA methylation. 5,10-methylenetetrahydrofolate assists in conversion of uracil to thymine and purine synthesis for DNA synthesis. MTHFR 677CT polymorphism alters the activity of MTHFR enzyme potentially effecting DNA repair and synthesis, hence a potential risk for cancer like breast cancer. Hence, the present study was conducted to evaluate association of MTHFR 677CT polymorphism and breast cancer in Punjabi population. Moreover, a meta-analysis was conducted to address the same.A total of 247 breast cancer patients and 247 controls were selected from Punjabi population for analysis using PCR-RFLP method. For meta-analysis, 67 studies were selected, and allele contrast, homozygous, heterozygous, dominant, and recessive models were used to evaluate the association between MTHFR 677CT and breast cancer.The frequencies of CC, CT, and TT genotype were 68.4% versus 74.5%, 28.7% versus 23.5%, and 2.9% versus 2.0% in patients and controls, respectively. There was no significant difference found. In meta-analysis, significant association was found in overall and Asian population while no significant association was found in Caucasians.MTHFR 677CT polymorphism is not a risk factor for breast cancer in Punjabi population. Inconsistency with the meta-analysis can be due to ethnic diversity.

Details

ISSN :
19984138
Volume :
18
Issue :
6
Database :
OpenAIRE
Journal :
Journal of cancer research and therapeutics
Accession number :
edsair.pmid..........45b1a123ffcd6b909fc5f918859f1a85